Skip to main content

Day: May 19, 2022

ObsEva Announces Appointment of Annette Clancy as Chair of the Board of Directors

GENEVA, Switzerland May 19, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced the appointment of Annette Clancy as Chair of the Board of Directors at the Company’s Annual General Meeting on May 18, 2022. Ms. Clancy has served as a member of ObsEva’s Board of Directors since 2013 and was previously Chair from November 2013 to December 2016. Ms. Clancy succeeds Dr. Frank Verwiel, who had decided to step down from the role of Chair and retire from the Board of Directors, effective following the conclusion of the Annual General Meeting. “We could not be more pleased, or fortunate, to have Annette return to the Chair position as we prepare for our first approvals and transition to a commercial stage company,” said Brian O’Callaghan, CEO...

Continue reading

PowerTap Provides Corporate Update

VANCOUVER, British Columbia and IRVINE, Calif., May 19, 2022 (GLOBE NEWSWIRE) — PowerTap Hydrogen Capital Corp (NEO: MOVE) (FWB: 2K6B) (OTC: MOTNF) (“PowerTap” or the “Company” or “MOVE”) is pleased to provide an update on its zoning application activities for its initial stations in Humboldt County in Northern California. In the first half of May 2022, PowerTap Hydrogen Fueling Corp. staff and consultants, as well as an Andretti Group representative, appeared before the City of Fortuna Planning Commission for the public hearing to review the site design for the first Andretti station incorporating a PowerTap Gen3 modular blue hydrogen production and dispensing unit (MHPDU), to be located in Fortuna, in Humboldt County, California. The proposal for the site design, which consisted of proposed elevations, landscaping, building colors,...

Continue reading

Premier Health Reports FY2022 Second Quarter Results

MONTRÉAL, May 18, 2022 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its second quarter ended March 31, 2022. SummaryThe Corporation had revenues of $17.6M for the 3-month period compared to $17.0M for the same period in FY2021, representing a 3.4% increase mainly attributable to organic growth over the period. The 24.7% gross margin for the quarter was close to the Corporation’s 25% target. EBITDA(1) for the quarter was $0.5M compared to $1.6M for the same period in FY2021. Net income was -$0.8M compared to $0.3M for the same period in FY2021.“We invested in our capacity to manage a wider geographical footprint” Said Martin Legault,...

Continue reading

Kayne Anderson Energy Infrastructure Fund Announces Completion of Private Placement of Notes

HOUSTON, May 18, 2022 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today that it completed its previously announced private placement of $45 million of 4.57% Series RR senior unsecured notes (“Notes”). These proceeds will be used to refinance existing leverage and for general corporate purposes. As previously announced, the remaining funding of the $45 million of 4.67% Series SS Notes and $20 million of 5.07% Series T MRP Shares will be issued on August 2, 2022. Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE: KYN) is a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended, whose common stock is traded on the NYSE. The Company’s investment objective is to provide a high after-tax total return with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.